Cryptococcus gattii meningitis in an immunocompromised patient in a hospital in the Peruvian Amazon: case report

Angel A Moreno-Soto1, Rodrigo J Cardenas-Golac1, Marco F Paredes-Obando1

  • 1Universidad Nacional de la Amazonía Peruana, Iquitos, Perú.

Insights

Cryptococcus gattii meningitis occurred in an HIV patient in the Peruvian Amazon. An alternative treatment was used due to resource limitations, highlighting the need for adapted strategies in such settings.

Area of Science:

  • Infectious Diseases
  • Mycology
  • Tropical Medicine

Background:

  • Cryptococcal meningitis is a significant opportunistic infection in individuals with advanced HIV.
  • Cryptococcus gattii is an emerging pathogen causing meningitis, particularly in immunocompromised hosts.
  • Resource-limited settings present challenges in diagnosing and treating fungal infections like cryptococcosis.

Observation:

  • A 36-year-old male with HIV presented with severe neurological symptoms.
  • Cerebrospinal fluid culture confirmed Cryptococcus gattii meningitis.
  • Standard antifungal therapy was unavailable; an alternative regimen of amphotericin B deoxycholate and fluconazole was administered.

Findings:

  • The patient received an alternative antifungal regimen due to resource constraints.
  • Treatment faced challenges, including persistent microorganism detection.
  • Despite challenges, the patient survived, indicating potential effectiveness of adapted therapeutic strategies.

Implications:

  • This case underscores the importance of considering Cryptococcus gattii in the differential diagnosis of cryptococcal meningitis in immunocompromised patients, irrespective of geographical prevalence.
  • The successful management highlights the need for adaptable diagnostic and therapeutic approaches in resource-limited settings.
  • Further research is warranted to optimize antifungal strategies for Cryptococcus gattii infections in underserved regions.

Related Concept Videos

Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
202
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
321
Transmission-based Precautions II: Airborne and Protective Environment01:25

Transmission-based Precautions II: Airborne and Protective Environment

Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
1.5K
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
439
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
326
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
343